Sight Sciences

Sight Sciences is a growing medical device company transforming two of the fastest-growing segments in eye care and optometry: glaucoma and dry eye disease. Founded in 2011, the company has developed intelligently designed and engineered products that target the root causes of some of the world’s most prevalent eye diseases, which are now commercially available.The company’s surgical glaucoma portfolio features the OMNI™ Glaucoma Treatment System, a dual-indication device that facilitates the performance of trabeculotomy and intracanalicular viscoelastic delivery. Its non-surgical dry eye portfolio includes TearCare®, now commercially available in the United States for ophthalmologists and optometrists. TearCare is a software-controlled wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids to address conditions such as meibomian gland dysfunction and dry eye disease.